BERMES seleccionat pel E-pitch InvestHorizon Healthcare 2020
Aromics' CEO Dr. Plasencia will present the advances on its BERMES project at the E-pitch Healthcare forum that will take place online next 9th June 2020. The company is one of the eight companies selected to pitch in front of the most important healthcare investors in Europe.
Bermes project is focused on its innovative anticancer therapy for treating malignant mesothelioma, a rare but very aggresive and incurable cancer related to asbestos exposure. The project received the support of the European Commission under the Horizon 2020 SME funding program.
InvestHorizon fosters the investment readiness of Europe’s ambitious high-tech companies. The Investment Accelerator fast tracks the fund-raising efforts and investment relations for selected companies. InvestHorizon is financed and promoted by the European Commission in association with Eureka and delivered by a consortium, coordinated by Tech Tour of which BPI and EBN is a key part. The event will focus on the healthcare sector.